Severe obesity and global developmental delay in preschool children: Findings from a Canadian Paediatric Surveillance

Nicole D Gehring1, Catherine S Birken2, Stacey Belanger3

  • 1School of Public Health, University of Alberta, Edmonton, Alberta, Canada.

Insights

Severe obesity and global developmental delay co-occur in Canadian preschoolers, with a minimum incidence of 3.3 per 100,000. Early identification and genetic testing are crucial for managing these complex cases.

Area of Science:

  • Pediatric Health
  • Developmental Pediatrics
  • Obesity Research

Background:

  • The co-occurrence of severe obesity (SO) and global developmental delay (GDD) in Canadian preschool children is not well-documented.
  • SO and GDD may necessitate specific syndromic diagnoses and tailored management strategies.

Purpose of the Study:

  • To determine the minimum incidence of co-occurring SO and GDD in Canadian children aged 5 years and under.
  • To identify the age of onset and risk factors associated with this dual diagnosis.
  • To examine health care utilization patterns for children with co-presenting SO and GDD.

Main Methods:

  • Utilized the Canadian Paediatric Surveillance Program (CPSP) with monthly reporting forms from February 2018 to January 2020.
  • Included children aged 5 years and under with new diagnoses of SO and GDD.
  • Employed descriptive statistics and qualitative content analysis for collected data.

Main Results:

  • Forty-seven cases were identified (64% male; mean age 3.5 years), with minimum incidence at 3.3 cases per 100,000 annually.
  • Common co-occurring issues included behavioral problems, snoring, and asthma; maternal obesity and neonatal intensive care were noted risk factors.
  • Genetic testing (microarray) was performed on 57% of children, and diverse clinical services were accessed, though family and service access challenges were reported.

Conclusions:

  • Children with co-occurring SO and GDD present with multiple comorbidities requiring prompt identification and specialized care.
  • Early referral to appropriate services and consideration of genetic testing for obesity syndromes are recommended.
  • Addressing barriers to care for families is essential for effective management.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
556
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
134
Binge Eating Disorders01:23

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
150
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
209
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K